Arbutus Biopharma (ABUS) Common Equity (2010 - 2026)
Arbutus Biopharma (ABUS) posted Common Equity of $258.73 million for Q2 2026, up 211.8% from $82.98 million a year earlier but down 0.6% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma's Common Equity came in at $76.58 million, down 21.4% from FY2024.
- Annual Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
- In prior years, Arbutus Biopharma's Common Equity was $97.37 million in FY2024 (-8.2%), $106.02 million in FY2023 (-22.5%), $136.85 million in FY2022 (-19.2%) and $169.44 million in FY2021 (+66.2%).
- Quarterly Common Equity has run from a low of $76.58 million in Q4 2025 to a high of $260.18 million in Q1 2026 over five years.
- On a year-over-year basis, Common Equity increased in two of the last eight quarters, with growth averaging 38.7%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2026, with growth of 228.7%; the weakest was Q2 2025, with a decline of 32.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $260.18 million (Q1 2026), $76.58 million (Q4 2025) and $77.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 258.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 258.73 Mn |
| Mar 31, 2026 | 260.18 Mn |
| Dec 31, 2025 | 76.58 Mn |
| Sep 30, 2025 | 77.40 Mn |
| Jun 30, 2025 | 82.98 Mn |
| Mar 31, 2025 | 79.16 Mn |
| Dec 31, 2024 | 97.37 Mn |
| Sep 30, 2024 | 106.89 Mn |
| Jun 30, 2024 | 122.45 Mn |
| Mar 31, 2024 | 114.64 Mn |
| Dec 31, 2023 | 106.02 Mn |
| Sep 30, 2023 | 119.34 Mn |
| Jun 30, 2023 | 134.69 Mn |
| Mar 31, 2023 | 143.92 Mn |
| Dec 31, 2022 | 136.85 Mn |
| Sep 30, 2022 | 145.52 Mn |
| Jun 30, 2022 | 153.14 Mn |
| Mar 31, 2022 | 165.85 Mn |
| Dec 31, 2021 | 169.44 Mn |
| Sep 30, 2021 | 130.14 Mn |
API Access
Arbutus Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();